The Max Foundation welcomes John Menapace as CFO/VP of Administration

The Max Foundation welcomes John Menapace as CFO/VP of Administration

We are delighted to announce that John Menapace has joined the Max Foundation as CFO/VP of Administration.

John brings demonstrated business leadership to his new role with a background comprising more than 20 years of experience in driving growth and profitability, across Fortune 50, Big 5, non-profit, and start-up companies.  His prior roles include positions of increasing responsibility within such leading organizations as the  American Red Cross, Clinton Health Access Initiative, and Kedrion Biopharma.  Most recently, he was CFO of The Floating Hospital in New York, one of New York City’s oldest healthcare charities with over 150 years of service to the neediest New Yorkers.

“I feel privileged to be joining The Max Foundation team,” says John. “Having worked in several charitable organizations, I am familiar with the Max Foundation’s lifesaving mission of acting as a bridge between patients and treatment while focusing on those no one else is helping. I am honored to be a part of this deeply humanitarian effort and look forward to actively supporting and working towards fulfilling our near- and long-term goals.”

 “We are at a pivotal period of growth and expansion at the Max Foundation, adds Pat Garcia-Gonzales, CEO of the Max Foundation.  “With John’s richly diverse experience including enterprise transformation and creating value across international markets, he is well suited to lead us into this next phase of growth and evolution as we strategically expand our external partnerships and internal talent”.

We’re excited about the depth and caliber of John’s background and look forward to his contributions as we further extend the Max Foundation’s mission of ensuring safe, high-impact medicine for all patients around the globe.

Please join us in welcoming John Menapace to the Max Foundation and wishing him much success.

See All News

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

Related Articles

  • The Max Foundation Creates Subsidiary Organization, MaxAid, to Further Mission

    Now in its 20th year, The Max Foundation is undergoing exciting strategic changes aimed at strengthening organizational efforts to improve global access to cancer treatment, care and support. To that end, we announce the launch of MaxAid, a subsidiary organization set up by The Max Foundation to further its mission. MaxAid is a Washington nonprofit corporation with its own IRS determination letter of 501(c)(3) public charity status.

  • The Max Foundation Partners with Leading Pharmaceutical Company to Advance Health Equity Through Expanded CML Treatment Access for Patients in 36 Low-Middle-Income Countries

    Availability of Novartis Scemblix® (asciminib) starting in 2023 helps ensure people living with later lines of CML in low-income countries have access to the latest innovation SEATTLE – Dec. 12, 2022 – The Max Foundation (Max), a global nonprofit organization that aims to accelerate health equity by delivering medication, technology, and supportive services to patients globally,….

  • The Max Foundation and Friends of Max Strengthen Partnership

    Hyderabad, India– The Max Foundation (Max) and Friends of Max (FOM) proudly announce the formalization of their long standing collaboration supporting people living with chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST) in India. The two organizations signed a landmark Memorandum of Understanding (MOU) at the recent Friends of Max 2015 Leadership Summit attended….